Air Products (APD)

NYSEMaterialsChemicals - SpecialtySnapshot 2026-10-15

$299.59+1.01%

Close 2026-10-16 · 1-day change

Read the published Living FV report summary

Investment OutlookAs of Oct 15, 2026

What could strengthen or challenge Air Products’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Living FV™

Living Fair Value by QuarterlyIQ

A valuation that evolves as the business changes.

A published Living FV snapshot is not available yet. The valuation workflow remains discoverable; a market target cannot supply the missing evidence.

View Living FV report and workflow

What the Thesis Depends On

Three key conditions need to be met for the investment thesis to play out.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Capital expenditures near $4 billion in fiscal 2026	Capital spending stays near $4 billion.	Intact	Capital expenditures exceed $4.5 billion in FY26	Capital expenditures: $995.7M FY2026-Q3; GAAP. Published target: ~$4 billion. Target period is not explicitly aligned with this observation. Source published Jul 30, 2026995,700,000 USD · source valueSource reportLast status assessment Oct 15, 2026 Measurement source consolidated · GAAP FY2026-Q3 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q3. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Full-year adjusted EPS of $13.12 in fiscal 2026	Air Products raised full-year EPS guidance to about $13.12.	Broken	Adjusted EPS falls below $13.00 in FY26	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated in 4 of last 4 quarters. Air Products raised its fiscal 2026 full-year adjusted EPS guidance from a range of $12.85-$13.15 in 2025-Q4 and 2026-Q1 to $13.00-$13.25 in 2026-Q1 and further to $13.39-$13.49 in 2026-Q2. This reflects management's consistent emphasis on earnings growth, with guidance trajectory showing incremental upward revisions, indicating delivery on this priority. Delivery assessment Oct 15, 2026
Revenue growth of about 7% per year	Air Products raised full-year EPS guidance to about $13.12.	Intact	Revenue growth falls below 5% YoY next year	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated in 4 of last 4 quarters. Air Products raised its fiscal 2026 full-year adjusted EPS guidance from a range of $12.85-$13.15 in 2025-Q4 and 2026-Q1 to $13.00-$13.25 in 2026-Q1 and further to $13.39-$13.49 in 2026-Q2. This reflects management's consistent emphasis on earnings growth, with guidance trajectory showing incremental upward revisions, indicating delivery on this priority. Delivery assessment Oct 15, 2026

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2028 · fiscal year ending 2028-09-30 · fmp

FY2028 EPS$15.66

$15.62 → $15.66 · observed estimates

FY2028 revenue$14.29B

$14.33B → $14.29B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2028 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-10-01	$15.62	$14,327,820,724	5 / 16
2026-10-02	$15.62	$14,327,820,724	5 / 16
2026-10-03	$15.62	$14,327,820,724	5 / 16
2026-10-04	$15.62	$14,327,820,724	5 / 16
2026-10-05	$15.62	$14,327,820,724	5 / 16
2026-10-06	$15.63	$14,332,950,640	5 / 16
2026-10-07	$15.63	$14,332,950,640	5 / 16
2026-10-08	$15.63	$14,285,319,925	5 / 16
2026-10-09	$15.63	$14,285,319,925	5 / 16
2026-10-10	$15.63	$14,285,319,925	5 / 16
2026-10-11	$15.63	$14,285,319,925	5 / 16
2026-10-12	$15.63	$14,285,319,925	5 / 16
2026-10-13	$15.63	$14,285,319,925	5 / 16
2026-10-14	$15.66	$14,285,319,925	5 / 16
2026-10-15	$15.66	$14,285,319,925	5 / 16

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	15	10
2026-06-01	14	9
2026-07-01	14	9
2026-08-01	14	7
2026-09-01	15	8
2026-10-01	16	7

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 16 Buy / Strong Buy · 7 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades2 maintains

Recent actions · Sep 16–Oct 15 · 2 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

RBC CapitalOct 15 · prior Jul 17

$358.00 → $346.00-3.4%

BarclaysOct 12

$353.00New observation · no comparable prior

UBSOct 5

$305.00New observation · no comparable prior

$0$196.90$393.80

0 raises · 1 cuts · 0 unchanged · 2 without a comparable prior

How this is measured

Sep 16, 2026–Oct 15, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Capital expenditures near $4 billion in fiscal 2026Capital expenditures: $995.7M
Full-year adjusted EPS of $13.12 in fiscal 2026Published status: Broken
Revenue growth of about 7% per yearDirect metric needs a verified mapping

Next proof point

Nov 5, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.0%Typical daily move · historical

Downside history

-13.0%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Air Products outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 10, 2026

What kind of bet this is

This investment represents a durable compounder with a focus on industrial gases. The current thesis state is cautious, as recent performance has been neutral and the stock has seen downward pressure.

What's priced into Air Products

The market currently prices APD at a premium compared to its peers, indicating that expectations are somewhat high. The valuation is considered expensive, with an expectations gap suggesting that investors are anticipating solid performance despite recent challenges.

What the fundamentals likely do

Management has shown a strong commitment to raising earnings guidance, which could support future performance. However, recent financial results have been mixed, and there is a moderate risk of missing future estimates.

What Air Products hinges on

The long-term thesis hinges on management's ability to maintain earnings growth and navigate sector challenges. Key factors include guidance updates, inflation trends, and performance of sector peers, which could influence investor sentiment.

Bottom line

Overall, APD's outlook remains cautious as it navigates a challenging environment while focusing on core strengths. Not investment advice.

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.